Saudi Arabia Sleep Apnea Devices Market, By Type (Therapeutic Devices, Diagnostic Devices), By Indication (Obstructive Sleep Apnea, Central Sleep Apnea), By End User (Hospitals & Clinics, Homecare), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Saudi Arabia Sleep Apnea Devices market was valued at USD 4.35 billion in 2024 and is expected to reach USD 5.94 billion by 2030 with a CAGR of 5.28%. The Saudi Arabia Sleep Apnea Devices Market has experienced consistent growth, primarily driven by increased awareness of sleep disorders, notably Obstructive Sleep Apnea (OSA), and a corresponding rise in demand for both diagnostic and therapeutic solutions. The market spans a variety of products tailored to address sleep-related breathing disorders, including polysomnography (PSG) devices, home sleep apnea testing (HSAT) kits, and therapeutic devices such as CPAP (Continuous Positive Airway Pressure) machines, BiPAP (Bilevel Positive Airway Pressure) devices, and oral appliances.

The Saudi Arabia Sleep Apnea Devices Market is set for sustained expansion. The growing awareness, coupled with increasing diagnosis rates and continuous technological innovations in sleep apnea treatments, will further propel the adoption of advanced devices. Moreover, government initiatives, particularly those outlined in Vision 2030, focused on enhancing healthcare access and improving chronic disease management, are expected to play a pivotal role in supporting the market's continued growth.

Key Market Drivers

Rising Prevalence of Sleep Disorders and Obstructive Sleep Apnea (OSA)

The growing prevalence of sleep disorders, particularly Obstructive Sleep Apnea (OSA), is driving the growth of the Saudi Arabia Sleep Apnea Devices Market. Studies suggest that about 33% of middle-aged men and 39% of women in Saudi Arabia are at high risk of OSA.

Obesity, type 2 diabetes, and cardiovascular diseases, which are widespread in the country, are key risk factors for OSA. Obesity alone affects a large share of adults and directly contributes to airway obstruction during sleep. The rise in these conditions increases the number of people requiring diagnostic tools like polysomnography (PSG) and therapeutic devices such as CPAP and BiPAP machines.

Sleep apnea has been widely underdiagnosed due to low public awareness, with research showing that 39% of people have limited knowledge about OSA. However, public health campaigns and increased media coverage have improved awareness, prompting more individuals to seek diagnosis and treatment. Sleep clinics and hospitals are now recording higher patient volumes, driving demand for diagnostic and long-term therapy devices.

Sleep medicine infrastructure is expanding, especially in Riyadh, Jeddah, and Dammam, where new centers are equipped with advanced diagnostic systems. Despite this progress, there are only 37 certified sleep medicine specialists in the country, a ratio of 0.012 per 100,000 people, far below international standards, indicating a shortage of specialized care.

This growing attention to sleep health is creating opportunities for medical device manufacturers and distributors. With OSA requiring continuous treatment, demand for CPAP devices remains strong. Patients now prefer portable, comfortable, and digitally connected devices that support therapy at home or during travel. Companies offering smart features such as automatic pressure adjustment, wireless data sharing, and remote monitoring are gaining a competitive advantage in the expanding market.

Growing Geriatric and At-Risk Population

The expansion of the geriatric population, along with a sharp rise in individuals classified as medically at-risk, is significantly influencing the growth trajectory of the Saudi Arabia Sleep Apnea Devices Market. Saudi Arabia is witnessing a substantial increase in its elderly population, with some projections forecasting a five-fold surge in individuals aged 60 and above between 2020 and 2050. By 2050, it is projected that this demographic will represent more than a fifth of the total population, creating challenges and opportunities for the healthcare sector.​

Advancing age is one of the most well-documented risk factors for Obstructive Sleep Apnea (OSA). As individuals age, changes in airway structure increase the likelihood of collapse during sleep. Moreover, aging is associated with a higher prevalence of comorbidities such as hypertension, atrial fibrillation, and stroke, which are strongly linked to sleep-disordered breathing. Recent data shows that over half of Saudi adults aged 60 and older have two or more chronic conditions, with 67% classified as overweight or obese.​

Older adults and patients with chronic health conditions are typically more engaged with the healthcare system, leading to greater clinical attention to the diagnosis and treatment of sleep apnea. This directly increases demand for polysomnography devices, CPAP therapy units, and auto-adjusting PAP systems. Primary care providers and geriatricians are becoming increasingly proactive in screening elderly patients for sleep-related symptoms. Apart from age, Saudi Arabia is witnessing a rise in chronic non-communicable diseases such as diabetes, obesity, and cardiovascular disease. These conditions are not only risk factors for OSA but also exacerbate its impact, creating a recurring market for sleep apnea treatment products among patients who require long-term therapy.

Download Free Sample Report

Key Market Challenges

Low Awareness and Underdiagnosis of Sleep Apnea

Despite increasing public health initiatives, a lack of awareness about sleep apnea remains one of the most significant barriers to market expansion in Saudi Arabia. Many individuals suffering from Obstructive Sleep Apnea (OSA) are unaware of their condition, often mistaking symptoms like fatigue, loud snoring, and disrupted sleep for unrelated health issues or lifestyle factors.

Compounding this issue is a low level of clinical diagnosis, particularly in rural and semi-urban areas. Limited knowledge among general practitioners and primary care providers regarding sleep medicine often leads to missed or delayed referrals to sleep specialists. This results in a large pool of undiagnosed patients who do not enter the treatment pipeline, thereby directly suppressing demand for diagnostic equipment and therapeutic devices such as CPAP machines.

Limited Availability of Specialized Sleep Centers and Trained Personnel

The Saudi healthcare infrastructure, while rapidly advancing, still lacks sufficient specialized sleep laboratories and trained sleep medicine professionals. Most sleep labs are concentrated in major urban centers like Riyadh and Jeddah, leaving large parts of the country underserved.

This geographical imbalance creates accessibility challenges for patients in remote or underserved areas, who often need to travel long distances for sleep testing or follow-up care. Moreover, there is a noticeable shortage of certified sleep technicians, respiratory therapists, and trained physicians, which slows down patient evaluation and treatment initiation. This infrastructure gap poses a significant obstacle to scaling up the diagnosis and long-term management of sleep apnea on a national level.

Key Market Trends

Integration of Digital Health and Remote Patient Monitoring

A defining trend in the Saudi sleep apnea market is the integration of digital health technologies, particularly remote monitoring platforms and cloud-based data analytics. Devices such as smart CPAP machines, including models like the ResMed AirSense 10 and 11 available in the Kingdom, now offer real-time data transmission, mobile app connectivity, and automated compliance tracking, enabling physicians to monitor patient adherence without requiring frequent in-person visits.​

This shift is especially relevant in Saudi Arabia’s growing urban and tech-savvy population and aligns with the national push toward e-health under Vision 2030, which has seen platforms like Sehhaty and Mawid gain millions of users. Remote monitoring, a practice that has seen accelerated adoption for sleep apnea patients, not only improves clinical outcomes by promoting adherence but also enhances the scalability of treatment services across the country. This trend is expected to accelerate adoption, especially in homecare settings, while enabling providers to deliver personalized, data-driven therapy.

Emergence of Local Manufacturing and Regional Assembly

Another important trend is the gradual emergence of local manufacturing and assembly partnerships within Saudi Arabia and the wider GCC region. In alignment with the Kingdom's Vision 2030 and its economic diversification strategy, several international medical device firms are establishing local production units and joint ventures. For example, the Saudi company ProMedEx formed a joint venture with China's Zhende Medical and MedSurg to manufacture medical supplies locally, with ProMedEx holding a 35% stake.​

This movement, supported by government incentives like subsidized loans and land, aims to reduce supply chain dependency, lower import costs, and accelerate product availability in the local market. Over time, it will lead to improved customization of devices to suit regional needs and potentially introduce more competitively priced offerings. This strategy is also positioning Saudi Arabia as a regional hub for medical technology, as evidenced by joint ventures like Cerba HealthCare Saudi Arabia in Riyadh, which aim to serve the broader Middle East.

Segmental Insights

Type Insights

Based on the category of Type, the Therapeutic Devices segment emerged as the fastest-growing segment in the Saudi Arabia Sleep Apnea Devices Market in 2024. This is primarily due to the chronic nature of Obstructive Sleep Apnea (OSA), which requires continuous, long-term management rather than a one-time diagnosis. Once a patient is diagnosed, the demand shifts toward treatment continuity, positioning therapeutic devices as the core revenue generator. Among therapeutic devices, Continuous Positive Airway Pressure (CPAP) machines represent the gold standard in OSA therapy and account for a substantial portion of the overall market value. Other sub-categories include BiPAP machines, AutoPAP devices, humidifiers, and oral appliances, all of which serve diverse patient profiles and severity levels.

Therapeutic devices are not only dominant, they are also emerging as the fastest-growing segment in the Saudi market. Several factors contribute to this accelerated growth: Rising diagnosis rates driven by increasing public awareness. Growing patient compliance due to the availability of portable, user-friendly, and smart-enabled CPAP devices. Expansion of home healthcare services, which favor therapeutic solutions for convenience and long-term use. The recurring revenue model from accessories and consumables such as masks, tubing, and filters. Advancements in remote monitoring and Bluetooth-enabled therapy management have improved adherence and made these devices more appealing to both patients and clinicians, thereby accelerating adoption. These factors are expected to drive the growth of this segment.

Indication Insights

Based on the category of Indication, the Obstructive Sleep Apnea segment emerged as the dominating segment in the Saudi Arabia Sleep Apnea Devices Market in 2024. The high prevalence of OSA is attributed to several interrelated factors, such as High obesity rates in the population (a major risk factor for OSA), increased incidence of hypertension, diabetes, and metabolic syndrome. Anatomical predispositions, such as narrow upper airways or enlarged tonsils, are particularly common in males. These clinical realities have made OSA the primary focus of both diagnosis and treatment protocols across public and private healthcare institutions in the Kingdom.

Due to the chronic and progressive nature of OSA, there is a consistent and high demand for therapeutic interventions, particularly CPAP (Continuous Positive Airway Pressure) devices, Auto-CPAP and BiPAP machines, Oral appliances, and positional therapy devices. Since OSA requires long-term management, the recurring nature of treatment and device dependency positions this indication segment as the primary revenue generator in the overall sleep apnea market. Government-led initiatives under Saudi Vision 2030 emphasize the importance of addressing lifestyle-related chronic diseases, including OSA. Medical institutions are enhancing screening programs for OSA as part of broader chronic disease management, further reinforcing this segment’s dominance. Increased public awareness campaigns about snoring, excessive daytime sleepiness, and sleep quality have led to higher rates of self-reporting and diagnosis of OSA, reinforcing demand for both diagnostic and therapeutic devices.

Download Free Sample Report

Regional Insights

Western Region, which includes major cities such as Jeddah and Mecca, stands out as the largest market for sleep apnea devices in Saudi Arabia. Jeddah, a commercial hub, and Mecca, a major pilgrimage site, are home to a dense and diverse urban population. This region boasts advanced healthcare facilities, specialized sleep centers, and medical professionals, contributing to higher awareness and diagnosis rates of sleep apnea. The Western region has high rates of obesity, diabetes, and hypertension, which are strongly correlated with Obstructive Sleep Apnea (OSA). Consequently, there is a high demand for both diagnostic and therapeutic devices, particularly CPAP and BiPAP machines. The presence of Mecca as a global religious destination further boosts demand for healthcare services, including sleep studies and apnea treatments, as many international pilgrims and visitors seek medical assistance during their stay. The region’s proximity to key importation hubs in Jeddah facilitates the steady supply of sleep apnea devices, contributing to its market dominance.

Recent Developments

• In September 2025, A notable trend in the Saudi market has been the increasing adoption of AI-enabled sleep apnea devices. These smart devices offer real-time data monitoring and are being used in both hospital and homecare settings to enhance personalized treatment and improve patient compliance.
• In February 2025, Nyxoah, a medical technology company, announced the commercial launch of its Genio® system in the United Arab Emirates (UAE). The Genio® system is a breakthrough, implantable neurostimulation therapy for treating Obstructive Sleep Apnea (OSA). This launch in a neighboring GCC country marks a significant step in making advanced, patient-centric alternatives to traditional CPAP therapy available in the wider Middle East region.
• In October 2024, Philips partnered with leading healthcare providers in Saudi Arabia to roll out connected respiratory devices. These devices feature remote patient monitoring capabilities, which are particularly beneficial for managing chronic respiratory conditions, including sleep apnea. This initiative aligns with the national push toward e-health and aims to improve treatment adherence and outcomes by allowing physicians to monitor patients' progress remotely.
• In January 2023, Vivos Therapeutics received FDA clearance for its mouthpiece designed to treat Obstructive Sleep Apnea (OSA), now classified as a Class II medical device. Previously, this device was designated as a Class I device for use as a palatal expander. With the new FDA approval, the device now carries an updated indication for OSA treatment, reflecting its evolving role in non-invasive therapeutic solutions for individuals suffering from this condition.

Key Market Players

• ResMed
• Philips
• Invacare Corporation
• Itamar Medical Inc.
• Nihon Kohden Middle East FZE

Report Scope:

In this report, the Saudi Arabia Sleep Apnea Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Sleep Apnea Devices Market, By Type:

o   Therapeutic Devices

o   Diagnostic Devices

• Saudi Arabia Sleep Apnea Devices Market, By Indication:

o   Obstructive Sleep Apnea

o   Central Sleep Apnea

• Saudi Arabia Sleep Apnea Devices Market, By End User:

o   Hospitals & Clinics

o   Homecare

• Saudi Arabia Sleep Apnea Devices Market, By Region:

o   Western

o   Central

o   Southern

o   Eastern

o   Northern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Sleep Apnea Devices Market.

Available Customizations:

 Saudi Arabia Sleep Apnea Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).